Le Lézard
Classified in: Health
Subjects: WOM, ASI, DEI

Podiatrists Encourage Asian Women to Seek Regular Care for Diabetes


Foot and ankle physicians and surgeons say women focus on families' needs at expense of their health.

BETHESDA, Md., Nov. 3, 2022 /PRNewswire/ -- Podiatrists are concerned about the growing prevalence of diabetes among Asian Americans and are sending a clear message, especially to Asian American women: It's time to start taking care of your diabetes. Foot and ankle surgeons say sociocultural factors among Asian Americans lead many women to devote themselves to their families to the detriment of their own health.

Asian women are a population at very high risk for serious complications from diabetes.

According to the Centers for Disease Control and Prevention, Asian Americans face a 40-percent higher risk of being diagnosed with diabetes than non-Hispanic white Americans. Among Asian Indians, that figure skyrockets to 70 percent.

The American Podiatric Medical Association (APMA) is marking November's Diabetes Awareness Month with a public education campaign designed to urge Asian women to take better care of themselves and to incorporate regular care from a podiatrist into their overall diabetes care. The campaign, It's Time, encourages Asian women with diabetes to take steps to manage their blood sugar, be alert to changes in their feet, and see a podiatrist for regular diabetic foot care. The campaign also dispels myths about diabetes that are common to Asian cultures.

"Asian Americans have an elevated risk of being diagnosed with diabetes," said APMA President Laura J. Pickard, DPM. "Combine that with a tendency to overlook self-care, and Asian women are a population at very high risk for serious complications from diabetes."

Asian women tend to put their families first, meaning they often overlook their own health needs. There are also common misconceptions about diabetes and its treatment options within the Asian community.

"Diabetes can cause serious complications in the feet, including non-healing wounds, infection, and even amputation," said Priya Parthasarathy, DPM, chair of the APMA Communications Committee. "That's why it's so important to educate this population about how they can manage their diabetes and protect their feet, which will keep them at the heart of their families."

To learn more about the campaign, visit www.apma.org/diabetes.

The American Podiatric Medical Association (APMA) is the nation's leading professional organization for today's podiatrists. Doctors of Podiatric Medicine (DPMs) are qualified by their education, training, and experience to diagnose and treat conditions affecting the foot, ankle, and structures of the leg. APMA has 53 component locations across the United States and its territories, with a membership of more than 12,500 podiatrists. All practicing APMA members are licensed by the state in which they practice podiatric medicine. For more information, visit www.apma.org.

Contact:
Peggy Tresky
[email protected]
301-581-9200

SOURCE American Podiatric Medical Association


These press releases may also interest you

11 mai 2024
eBlu Solutions, a leading provider of innovative technology solutions for the specialty healthcare industry, is pleased to announce the addition of Doug Lawrence to the Executive Leadership team in the role of Chief Revenue Officer. "We're not just...

11 mai 2024
NUVISTA Mental Health proudly announces its participation as a Gold Sponsor for the 2024 Ontario First...

11 mai 2024
Cardurion Pharmaceuticals, Inc. ("Cardurion"), a clinical-stage biotechnology company developing next-generation therapeutics for the treatment of cardiovascular diseases, today announced the presentation of positive clinical data from CARDINAL?HF,...

11 mai 2024
Dr. Majid Al Fayyadh, CEO of King Faisal Specialist Hospital and Research Centre (KFSH&RC) joined the Gulf Creatives Conference (GCC) at Harvard 2024. The event, GCC at Harvard, is organized by The Diwan, an organization run by graduate students at...

11 mai 2024
Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for use across a range of infectious disease, oncology,...

11 mai 2024
Caliway Biopharmaceuticals (Caliway) is pleased to announce its participation to share the latest clinical advancements at the upcoming 2024 BIO International Convention on Wednesday, June 5th, at 11:45 a.m. PDT. The presentation will take place in...



News published on and distributed by: